F-Seven Pharmaceutical Private Limited
About F-Seven Pharmaceutical Private Limited
Data last updated:
F-Seven Pharmaceutical Private Limited is a private limited company based in Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 14 February 1996 and has been in existence for over 30 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U33112DL1996PTC076314. The company has 1 GST registration on record, which is no longer active.
The company has an authorised share capital of ₹45 Lakh and a paid-up capital of ₹41.08 Lakh. It is led by directors including Suresh Kumar Aggarwal and Mayank Aggarwal.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 154 1st Floor Aggarwal Cyber Plaza – 1 Plot No – C – 4 5 6, Netaji Subhash Place Pitampura, Delhi, India – 110034.
As per the financials filed for FY 2025, the company reported a revenue of ₹6.6 Lakh, a decline of 52% compared to the previous year. For the same year it recorded a net profit of ₹1.94 Lakh (net margin 29.4%) and EBITDA of ₹4.41 Lakh (EBITDA margin 66.8%). Revenue has declined at a compounded annual rate (CAGR) of 31% over three years and 16% over five years.
As per MCA filings, the company has open charges of ₹8.75 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
F-Seven Pharmaceutical Private Limited's registered office is in Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address154 1st Floor Aggarwal Cyber Plaza – 1 Plot No – C – 4 5 6, Netaji Subhash Place Pitampura, Delhi, India – 110034
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of F-Seven Pharmaceutical Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of F-Seven Pharmaceutical Private Limited
FY 2025 filings availableF-Seven Pharmaceutical Private Limited reported revenue of ₹6.6 Lakh (down 52% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 16% over five years, including a 52% fall in the latest year. EBITDA fell 55% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹4.41 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.94 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 66.8% | ||||
| Net Profit Margin | 29.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of F-Seven Pharmaceutical Private Limited, buy the company report.
Board of directors of F-Seven Pharmaceutical Private Limited
F-Seven Pharmaceutical has 3 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Suresh Kumar Aggarwal Also directs: Mittaso Projects Private Limited, Unity Automobiles Private Limited, MV Promoters Private Limited and 2 more | Director | 20 Jan 2014 | 12 Years 9 Months | Current |
| Mayank Aggarwal | Director | 20 Jan 2014 | 12 Years 9 Months | Current |
| Nitin Aggarwal Also directs: MV Promoters Private Limited, Uni One Square LLP, Uni One Realtech Private Limited and 1 more | Director | 10 Jun 2024 | 2 Years 4 Months | Current |
Auditor
F-Seven Pharmaceutical Private Limited is audited by ARUN NARESH & CO for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| ARUN NARESH & CO | FY 2023 | 007127N |
Shareholding
The shareholding of F-Seven Pharmaceutical Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of F-Seven Pharmaceutical Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 11 Feb 2026 | 101233509 | Others | ₹3.75 Cr | Open | |
| 30 Nov 2024 | 101020063 | Others | ₹5 Cr | Open |
Total charge records: 2 View all charges
Legal cases
No court or tribunal cases involving F-Seven Pharmaceutical Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for F-Seven Pharmaceutical Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
F-Seven Pharmaceutical has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of F-Seven Pharmaceutical Private Limited, buy the company report.
Recent activity
F-Seven Pharmaceutical Private Limited has 9 board changes on record since 2000: 6 appointments and 3 cessations. The latest: Nitin Aggarwal was appointed as Director on 10 Jun 2024.
2 earlier events are in the company report.
Frequently asked questions
F-Seven Pharmaceutical is an active private limited company based in Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 14 February 1996 (30+ years old) and is registered under CIN U33112DL1996PTC076314.
F-Seven Pharmaceutical has 3 current directors:
- Suresh Kumar Aggarwal - Director
- Mayank Aggarwal - Director
- Nitin Aggarwal - Director
The latest financial statements of F-Seven Pharmaceutical on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
No. F-Seven Pharmaceutical has 1 GST registration on record and it is cancelled or inactive.
The CIN (Corporate Identification Number) of F-Seven Pharmaceutical is U33112DL1996PTC076314. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
F-Seven Pharmaceutical was incorporated on 14 February 1996, making it 30+ years old. It is registered with the Registrar of Companies, Delhi.
Nitin Aggarwal was appointed as Director on 10 Jun 2024. Roshan Lal ceased to be Director on 25 Jan 2014. Sourabh Bansal ceased to be Additional Director on 25 Jan 2014. F-Seven Pharmaceutical has 9 board changes on record in total.
The registered office of F-Seven Pharmaceutical is at 154 1st Floor Aggarwal Cyber Plaza – 1 Plot No – C – 4 5 6, Netaji Subhash Place Pitampura, Delhi, India – 110034.
F-Seven Pharmaceutical operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
F-Seven Pharmaceutical has open charges of ₹8.75 Cr and no satisfied charges on record as per latest MCA filings.